Verena Schöning

7PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesPharmacogenomicsInfectious diseasesHost-parasite interactionsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances.

|Apr 03, 2026
Improving Population Pharmacokinetic Modelling with Artificial Patients using Generative Artificial Intelligence.

Verena Schöning, Felix Hammann

|Oct 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study.

Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis

|Jul 01, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection.

Laura Hermann, Verena Schöning, Sarah Dräger

|Apr 27, 2024
Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa as Critical Mediators of AMPK Activation.

Jürgen Drewe, Verena Schöning, Ombeline Danton

|Sep 23, 2022
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.

Verena Schöning, Felix Hammann

Pageof 2

Frequent Collaborators

6 joint publications

Felix Hammann

2 joint publications

Jürgen Drewe

2 joint publications

Katharina Rentsch

2 joint publications

Michael Osthoff